$SNWV
SANUWAVE Health, Inc.

2020 Q4 Form 10-K Financial Statement

#000114036121035116 Filed on October 21, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019
Revenue $1.860M $336.2K $1.029M
YoY Change 453.32% -26.41% -44.39%
Cost Of Revenue $500.0K $136.3K $538.9K
YoY Change 266.92% -23.43% -22.31%
Gross Profit $1.360M $199.9K $489.8K
YoY Change 580.41% -28.31% -57.64%
Gross Profit Margin 73.12% 59.46% 47.61%
Selling, General & Admin $6.940M $2.384M $8.031M
YoY Change 191.17% 89.32% 20.76%
% of Gross Profit 510.29% 1192.47% 1639.64%
Research & Development $260.0K $314.1K $1.182M
YoY Change -17.22% 10.46% -28.97%
% of Gross Profit 19.12% 157.13% 241.3%
Depreciation & Amortization $565.1K $31.06K $71.21K
YoY Change 1719.35% 454.64% 218.91%
% of Gross Profit 41.55% 15.54% 14.54%
Operating Expenses $7.530M $2.729M $9.284M
YoY Change 175.96% 76.53% 11.37%
Operating Profit -$6.170M -$2.529M -$8.794M
YoY Change 143.99% 99.6% 22.48%
Interest Expense $1.160M -$221.3K -$1.635M
YoY Change -624.1% -72.48% -63.34%
% of Operating Profit
Other Income/Expense, Net -$2.920M $0.00 -$1.635M
YoY Change -16537.1%
Pretax Income $11.66M -$2.750M -$10.60M
YoY Change -523.99% 33.41% -8.91%
Income Tax $0.00
% Of Pretax Income
Net Earnings $11.66M -$2.750M -$10.43M
YoY Change -523.99% 33.41% -10.33%
Net Earnings / Revenue 626.88% -818.11% -1013.86%
Basic Earnings Per Share -$0.05
Diluted Earnings Per Share $21.86K -$10.14K -$0.05
COMMON SHARES
Basic Shares Outstanding 467.2M 203.6M
Diluted Shares Outstanding 203.6M

Balance Sheet

Concept 2020 Q4 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.440M $1.760M $1.760M
YoY Change 38.6% 382.91% 382.91%
Cash & Equivalents $2.437M $1.760M $1.760M
Short-Term Investments
Other Short-Term Assets $180.0K $125.4K $125.4K
YoY Change 43.53% 0.24% 0.24%
Inventory $2.956M $543.0K $543.0K
Prepaid Expenses
Receivables $2.356M $75.54K $75.54K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.928M $2.504M $2.504M
YoY Change 216.57% 131.14% 131.14%
LONG-TERM ASSETS
Property, Plant & Equipment $471.0K $93.95K $835.7K
YoY Change 401.31% 20.83% 974.72%
Goodwill $7.260M $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $28.00K $41.93K $41.93K
YoY Change -33.22% 154.28% 154.28%
Total Long-Term Assets $15.10M $877.6K $877.6K
YoY Change 1620.42% 831.18% 831.17%
TOTAL ASSETS
Total Short-Term Assets $7.928M $2.504M $2.504M
Total Long-Term Assets $15.10M $877.6K $877.6K
Total Assets $23.03M $3.382M $3.382M
YoY Change 580.87% 187.16% 187.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.454M $1.439M $1.439M
YoY Change 209.43% -9.62% -9.62%
Accrued Expenses $2.127M $957.1K $4.597M
YoY Change 122.23% -56.52% 108.83%
Deferred Revenue $32.00K $66.58K
YoY Change -51.94%
Short-Term Debt $0.00 $587.2K $6.172M
YoY Change -100.0% -94.56% -42.8%
Long-Term Debt Due $16.59M $121.6K $121.6K
YoY Change 13542.19%
Total Short-Term Liabilities $36.17M $12.42M $12.42M
YoY Change 191.37% -24.7% -24.7%
LONG-TERM LIABILITIES
Long-Term Debt $143.0K $271.2K $271.2K
YoY Change -47.28%
Other Long-Term Liabilities $200.0K $759.0K $759.0K
YoY Change -73.65% 1523.88% 1523.88%
Total Long-Term Liabilities $571.0K $1.030M $1.030M
YoY Change -44.58% 2104.2% 2104.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.17M $12.42M $12.42M
Total Long-Term Liabilities $571.0K $1.030M $1.030M
Total Liabilities $36.75M $13.45M $13.45M
YoY Change 173.29% -18.68% -18.68%
SHAREHOLDERS EQUITY
Retained Earnings -$156.7M -$125.8M
YoY Change 24.6%
Common Stock $471.0K $293.8K
YoY Change 60.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.72M -$10.06M -$10.06M
YoY Change
Total Liabilities & Shareholders Equity $23.03M $3.382M $3.382M
YoY Change 580.87% 187.16% 187.16%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $11.66M -$2.750M -$10.43M
YoY Change -523.99% 33.41% -10.33%
Depreciation, Depletion And Amortization $565.1K $31.06K $71.21K
YoY Change 1719.35% 454.64% 218.91%
Cash From Operating Activities $22.50M -$1.726M -$6.411M
YoY Change -1403.47% 27.9% 77.04%
INVESTING ACTIVITIES
Capital Expenditures $89.14K -$24.95K $53.94K
YoY Change -457.27% 132.74% -225.76%
Acquisitions
YoY Change
Other Investing Activities $40.00M
YoY Change
Cash From Investing Activities $40.09M -$24.95K -$53.94K
YoY Change -160777.92% 132.74% 25.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 870.0 3.121M 7.860M
YoY Change -99.97% 88.67% 136.92%
NET CHANGE
Cash From Operating Activities 22.50M -1.726M -6.411M
Cash From Investing Activities 40.09M -24.95K -53.94K
Cash From Financing Activities 870.0 3.121M 7.860M
Net Change In Cash 62.59M 1.370M 1.396M
YoY Change 4467.57% 365.89% -502.8%
FREE CASH FLOW
Cash From Operating Activities $22.50M -$1.726M -$6.411M
Capital Expenditures $89.14K -$24.95K $53.94K
Free Cash Flow $22.41M -$1.701M -$6.465M
YoY Change -1417.35% 27.06% 80.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1439413
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4454385
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2355396
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75543
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
196614
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
134970
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
238730
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
0
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2126768
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
957109
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62234
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62282
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
628559
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
533893
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
142562694
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
115457808
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21900
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
333422
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
560682
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
186867
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
342898
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
72376
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
713021
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
484185
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46027476
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
232860531
CY2020Q4 us-gaap Assets
Assets
23027560
CY2019Q4 us-gaap Assets
Assets
3381992
CY2020Q4 us-gaap Assets Current
AssetsCurrent
7928067
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2504358
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
9003555
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7832221
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-35533724
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-15222591
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
676529
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1395906
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
364549
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1760455
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2436984
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2436984
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1760455
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
103994927
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9474091
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
190356736
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
470694621
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293780400
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
293781
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
470695
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
355000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
293780400
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
470694621
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30937081
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10409995
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify;"><font style="font-weight: bold; font-style: italic;">Concentration of credit risk and limited suppliers</font> - Management routinely assesses the financial strength of its customers and, as a consequence, believes accounts receivable are stated at the net realizable value and credit risk exposure is limited.</div><div><br /></div><div style="color: rgb(0, 0, 0);">As of December 31, 2020, receivables from Celularity (see Note 5) constituted approximately 46% of our accounts receivable balance.&#160; No other distributors or partners made up more than 10% of the Company&#8217;s revenues for the year ended December 31, 2020 or more than 10% of the Company&#8217;s accounts receivables as of December 31, 2020.</div><div><br /></div><div style="text-align: justify;">Three distributors and partners accounted for 18%, 15% and 12% of revenues for the year ended December 31, 2019, and 0%, 0% and 22% of accounts receivable at December 31, 2019.</div><div style="text-align: justify;"><br /></div><div>The Company depends on suppliers for product component materials and other components that are subject to stringent regulatory requirements.&#160; The Company currently purchases most of its product component materials from single suppliers and the loss of any of these suppliers could result in a disruption in our production.&#160; If this were to occur, it may be difficult to arrange a replacement supplier because certain of these materials may only be available from one or a limited number of sources.&#160; In addition, our suppliers could be disrupted by conditions related to COVID-19 or other epidemics.&#160; Establishing additional or replacement suppliers for these materials may take a substantial period of time as these suppliers must be approved by regulatory authorities.&#160; Three of the Company&#8217;s suppliers accounted for 41%, 24% and 11% of the Company&#8217;s purchases, respectively, during the year ended December 31, 2020.&#160; During the year ended December 31, 2019, one supplier accounted for approximately 65% of the Company&#8217;s purchases. No other suppliers made up more than 10% of the Company&#8217;s purchases.</div></div>
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32258
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
66577
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
573224
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
37514
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
69772
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
639801
CY2020 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
CY2019 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2933313
CY2019Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4000000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
538923
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
1162021
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1577
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-964218
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-409313
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28047903
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1811264
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
73705
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
4240
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
7754
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5420438
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2300997
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
8275235
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3559542
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
564729
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-3676
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23727093
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25878769
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32261848
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1613258
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1607841
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
20227
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
18649
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
426514
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
357869
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
287035
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
38323
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32261848
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25878769
CY2019 us-gaap Depreciation
Depreciation
37740
CY2020 us-gaap Depreciation
Depreciation
97956
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
298741
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71213
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
71213
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
781002
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5603229
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1618754
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-48
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1606910
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2540675
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3192620
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-227669
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
234593
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
452774
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.132
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
427429
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
392874
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
142699
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
58687
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
25345
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
233766
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
271240
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
33473
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
234258
CY2020Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingAndFinanceLeaseLiability
CY2019Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingAndFinanceLeaseLiability
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
199793
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
210333
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
84440
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
200785
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
33473
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
18388
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
121634
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
193663
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
60863
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
58804
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
451561
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
643517
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
409259
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
418088
CY2019 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
1159713
CY2020 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
1097577
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
703889
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
703889
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
703889
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
703889
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3025839
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
703889
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
7185120
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6545284
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-38201
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-26979
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-565374
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13723888
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6440093
CY2019Q4 us-gaap Goodwill
Goodwill
0
CY2020Q4 us-gaap Goodwill
Goodwill
7259795
CY2020 us-gaap Gross Profit
GrossProfit
2895450
CY2019 us-gaap Gross Profit
GrossProfit
489807
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7185120
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30945249
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10595457
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8216
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
165618
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2071322
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6498502
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2595
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1725
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6383079
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2713986
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-913233
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-291082
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-301177
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
356481
CY2020 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-570029
CY2019 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
468768
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2582046
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8600
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3014972
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-138730
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
267829
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1169659
CY2020 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-1228
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1288497
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
933765
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
553424
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
185135
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-13328
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
25440
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
53938
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
294
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1021495
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
516014
CY2019 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
688195
CY2019 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
40000
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
1147986
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
2025017
CY2020 us-gaap Interest Paid Net
InterestPaidNet
436333
CY2019 us-gaap Interest Paid Net
InterestPaidNet
0
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
357265
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1145737
CY2019Q4 us-gaap Inventory Net
InventoryNet
542955
CY2020Q4 us-gaap Inventory Net
InventoryNet
2956344
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1810607
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
279279
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
449164
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
34496
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3345
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8028
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
65010
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
185690
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2546192
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
28500
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
93502
CY2019 us-gaap Lease Cost
LeaseCost
251731
CY2020 us-gaap Lease Cost
LeaseCost
556275
CY2020Q4 us-gaap Liabilities
Liabilities
36746442
CY2019Q4 us-gaap Liabilities
Liabilities
13445593
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3381992
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23027560
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1030241
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
572452
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12415352
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36173990
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
1000000
CY2017Q4 us-gaap Line Of Credit
LineOfCredit
370000
CY2019 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
-680000
CY2018Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.06
CY2017Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.06
CY2020 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"><tr style="vertical-align: top;"><td style="vertical-align: top; width: 36pt;"><div style="text-align: justify;"><font style="font-weight: bold; color: rgb(0, 0, 0);">19.</font></div></td><td style="align: left; vertical-align: top; width: auto;"><div style="text-align: justify;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Contingencies</font></div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0);"><font style="font-weight: bold; font-style: italic;">Litigation - </font>From time to time, the Company is subject to various legal actions, claims and proceedings arising in the ordinary course of business, including claims related to breach of contracts and intellectual property matters resulting from our business activities. As with most actions such as these, an estimation of any possible and/or ultimate liability cannot always be determined. The Company believes that all pending claims, if adversely decided, would not have a material adverse effect on our business, financial position or results of operations.</div></div>
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7859969
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33447739
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12718292
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6410758
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53939
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20052870
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-10429839
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-30937033
CY2019 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0
CY2020 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
4000000
CY2020Q4 us-gaap Notes Payable To Bank
NotesPayableToBank
464335
CY2019Q4 us-gaap Notes Payable To Bank
NotesPayableToBank
0
CY2020Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
143628
CY2019Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
0
CY2019Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5372743
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
587233
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
14996344
CY2020Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
143628
CY2019Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
0
CY2019Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
0
CY2020Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
320707
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
257124
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
173270
CY2020Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingAndFinanceLeaseLiability
CY2019Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingAndFinanceLeaseLiability
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.099
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
157544
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
185777
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
302976
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
165403
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
476029
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
724604
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
296686
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
157395
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
414668
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
359047
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://sanuwave.com/20201231#OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
CY2020 us-gaap Operating Expenses
OperatingExpenses
28095257
CY2019 us-gaap Operating Expenses
OperatingExpenses
9284155
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-8794348
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-25199807
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19844
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6545284
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28602
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41931
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
634
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-48
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1635491
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5737226
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
147056
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
153769
CY2020 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
20000000
CY2019 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52870
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53939
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
179343
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
125405
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1758142
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1100000
CY2020 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
13346547
CY2019 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
90000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2450000
CY2019 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2055414
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22500
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48250
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
180000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2020 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
180000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
93954
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
470981
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1099540
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
627847
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39331
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
302193
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
476029
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
248575
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
451561
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
191956
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
5457662
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1181892
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1245507
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156689989
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125752956
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1028730
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4057471
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y3M18D
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
564729
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6492855
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1590957
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5159740
CY2020Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
10675637
CY2019Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
0
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
333422
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
21900
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0015
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.9276
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
587233
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
18098
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
325000
CY2020 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
4829789
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
28500
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2546192
CY2019 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
7020455
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48250
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-10063601
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-13718882
CY2020Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-15356099
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2019 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0);"><font style="font-weight: bold; font-style: italic;">Estimates</font> &#8211; These Consolidated Financial Statements have been prepared in accordance with U.S. GAAP.&#160; Because a precise determination of assets and liabilities, and correspondingly revenues and expenses, depend on future events, the preparation of consolidated financial statements for any period necessarily involves the use of estimates and assumptions.&#160; Actual amounts may differ from these estimates.&#160; These Consolidated Financial Statements have, in management&#8217;s opinion, been properly prepared within reasonable limits of materiality and within the framework of the accounting policies summarized herein.</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0);">Significant estimates include the recording of allowances for doubtful accounts,&#160; the net realizable value of inventory, useful lives of long-lived assets, fair value of goodwill and other intangible assets, the determination of the valuation allowances for deferred taxes, estimated fair value of stock-based compensation, and the estimated fair value of warrants.</div></div>
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2713986
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-6383079
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
203588106
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
378128645
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
203588106
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
378128645
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
378128645
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
203588106
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Entity Registrant Name
EntityRegistrantName
SANUWAVE Health, Inc.
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001417663
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
66700000
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
481619621
CY2020Q4 snwv Minimum Number Of Units Purchased By Related Party
MinimumNumberOfUnitsPurchasedByRelatedParty
100
CY2020 snwv Purchase Of Units Over Period By Related Party
PurchaseOfUnitsOverPeriodByRelatedParty
P3Y
CY2020 snwv Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
8200000
CY2019 snwv Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
94727180
CY2020Q2 snwv Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
1000000
CY2020Q3 snwv Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
35000000
CY2019 snwv Issuance Of Stock For Inducement
IssuanceOfStockForInducement
0
CY2020 snwv Issuance Of Stock For Inducement
IssuanceOfStockForInducement
44740
CY2020 snwv Waived Proceeds From Warrant Exercise
WaivedProceedsFromWarrantExercise
0
CY2019 snwv Waived Proceeds From Warrant Exercise
WaivedProceedsFromWarrantExercise
-36000
CY2020 snwv Warrants Issued For Consulting Services
WarrantsIssuedForConsultingServices
0
CY2019 snwv Warrants Issued For Consulting Services
WarrantsIssuedForConsultingServices
186867
CY2020 snwv Proceeds From Short Term Note
ProceedsFromShortTermNote
0
CY2019 snwv Proceeds From Short Term Note
ProceedsFromShortTermNote
1215000
CY2019 snwv Proceeds From Small Business Administration Ssba Loan
ProceedsFromSmallBusinessAdministrationSSBALoan
0
CY2020 snwv Proceeds From Small Business Administration Ssba Loan
ProceedsFromSmallBusinessAdministrationSSBALoan
614335
CY2019 snwv Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
35386
CY2020 snwv Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-6290
CY2020 snwv Conversion Of Line Of Credit Related Party To Accounts Receivable
ConversionOfLineOfCreditRelatedPartyToAccountsReceivable
0
CY2019 snwv Conversion Of Line Of Credit Related Party To Accounts Receivable
ConversionOfLineOfCreditRelatedPartyToAccountsReceivable
121000
CY2020 snwv Accounts Payable And Accrued Employee Compensation Converted To Equity
AccountsPayableAndAccruedEmployeeCompensationConvertedToEquity
0
CY2019 snwv Accounts Payable And Accrued Employee Compensation Converted To Equity
AccountsPayableAndAccruedEmployeeCompensationConvertedToEquity
36500
CY2019 snwv Conversion Of Line Of Credit Related Parties To Equity
ConversionOfLineOfCreditRelatedPartiesToEquity
680000
CY2020 snwv Conversion Of Line Of Credit Related Parties To Equity
ConversionOfLineOfCreditRelatedPartiesToEquity
0
CY2020 snwv Other Warrant Exercise
OtherWarrantExercise
0
CY2019 snwv Other Warrant Exercise
OtherWarrantExercise
1863815
CY2020 snwv Reclassification Of Warrant Liability To Equity
ReclassificationOfWarrantLiabilityToEquity
6292695
CY2019 snwv Reclassification Of Warrant Liability To Equity
ReclassificationOfWarrantLiabilityToEquity
1542000
CY2019 snwv Proceeds From Pipe Offering
ProceedsFromPipeOffering
2800100
CY2020 snwv Proceeds From Pipe Offering
ProceedsFromPipeOffering
21456468
CY2019 snwv Interest Payable Related Parties
InterestPayableRelatedParties
688195
CY2020 snwv Interest Payable Related Parties
InterestPayableRelatedParties
401081
CY2019 snwv Conversion Of Advance From Related Parties
ConversionOfAdvanceFromRelatedParties
0
CY2020 snwv Conversion Of Advance From Related Parties
ConversionOfAdvanceFromRelatedParties
18098
CY2020 snwv Conversion Of Notes Payable Related Parties
ConversionOfNotesPayableRelatedParties
2291047
CY2019 snwv Conversion Of Notes Payable Related Parties
ConversionOfNotesPayableRelatedParties
0
CY2020 snwv Series C And Series D Preferred Stock Converted To Common Stock
SeriesCAndSeriesDPreferredStockConvertedToCommonStock
2450000
CY2019 snwv Series C And Series D Preferred Stock Converted To Common Stock
SeriesCAndSeriesDPreferredStockConvertedToCommonStock
0
CY2020 snwv Exchange Line Of Credit And Notes Payable Related Parties For Convertible Promissory Notes Related Parties
ExchangeLineOfCreditAndNotesPayableRelatedPartiesForConvertiblePromissoryNotesRelatedParties
1596254
CY2019 snwv Exchange Line Of Credit And Notes Payable Related Parties For Convertible Promissory Notes Related Parties
ExchangeLineOfCreditAndNotesPayableRelatedPartiesForConvertiblePromissoryNotesRelatedParties
0
CY2019 snwv Conversion Of Advances From Related Parties To Equity
ConversionOfAdvancesFromRelatedPartiesToEquity
1827316
CY2019Q4 snwv Advances From Related Parties Current
AdvancesFromRelatedPartiesCurrent
18098
CY2020Q4 snwv Advances From Related Parties Current
AdvancesFromRelatedPartiesCurrent
22500
CY2019 snwv Advances From Related Parties To Short Term Note
AdvancesFromRelatedPartiesToShortTermNote
210000
CY2019 snwv Advances From Related Parties To Equity Through Issuance Of Common Stock
AdvancesFromRelatedPartiesToEquityThroughIssuanceOfCommonStock
18200000
CY2019 snwv Stock Issued During Period Value Conversion Of Promissory Notes
StockIssuedDuringPeriodValueConversionOfPromissoryNotes
2933313
CY2019 snwv Stock Issued During Period Shares Conversion Of Promissory Notes
StockIssuedDuringPeriodSharesConversionOfPromissoryNotes
26666487
CY2019 snwv Stock Issued During Period Shares Conversion Of Line Of Credit Related Parties To Equity
StockIssuedDuringPeriodSharesConversionOfLineOfCreditRelatedPartiesToEquity
225000
CY2020 snwv Stock Issued During Period Value Conversion Of Note Payable Related Party Debt
StockIssuedDuringPeriodValueConversionOfNotePayableRelatedPartyDebt
2291047
CY2019 snwv Stock Issued During Period Value Conversion Of Line Of Credit Related Parties To Equity
StockIssuedDuringPeriodValueConversionOfLineOfCreditRelatedPartiesToEquity
680000
CY2020Q4 snwv Liability Recorded
LiabilityRecorded
7306165
CY2020 snwv Stock Issued During Period Shares Conversion Of Note Payable Related Party Debt
StockIssuedDuringPeriodSharesConversionOfNotePayableRelatedPartyDebt
15475235
CY2020 snwv Stock Issued During Period Value Conversion Of Short Term Notes
StockIssuedDuringPeriodValueConversionOfShortTermNotes
210000
CY2020 snwv Stock Issued During Period Shares Conversion Of Short Term Notes
StockIssuedDuringPeriodSharesConversionOfShortTermNotes
2250000
CY2020 snwv Residual Value
ResidualValue
12682516
CY2020Q4 snwv Line Of Credit Related Parties Current
LineOfCreditRelatedPartiesCurrent
0
CY2019Q4 snwv Line Of Credit Related Parties Current
LineOfCreditRelatedPartiesCurrent
212388
CY2019Q4 snwv Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
0
CY2020Q4 snwv Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
1596254
CY2019 snwv Partnership Fee Received
PartnershipFeeReceived
0
CY2020 snwv Partnership Fee Received
PartnershipFeeReceived
600000
CY2019 snwv Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
416451
CY2020 snwv Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
186083
CY2020 snwv Business Combination Issuance Of Convertible Promissory Notes
BusinessCombinationIssuanceOfConvertiblePromissoryNotes
4000000
CY2019Q4 snwv Accrued Interest Payable Related Parties Current
AccruedInterestPayableRelatedPartiesCurrent
1859977
CY2020Q4 snwv Accrued Interest Payable Related Parties Current
AccruedInterestPayableRelatedPartiesCurrent
77145
CY2019Q4 snwv Warrant Liability Current
WarrantLiabilityCurrent
0
CY2020Q4 snwv Warrant Liability Current
WarrantLiabilityCurrent
8855379
CY2020Q4 snwv Operating Lease And Finance Lease Liability Noncurrent
OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
391310
CY2019Q4 snwv Operating Lease And Finance Lease Liability Noncurrent
OperatingLeaseAndFinanceLeaseLiabilityNoncurrent
457017
CY2020Q4 snwv Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
794831
CY2019Q4 snwv Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
741749
CY2019Q4 snwv Operating Lease And Finance Lease Liability Current
OperatingLeaseAndFinanceLeaseLiabilityCurrent
294904
CY2020Q4 snwv Operating Lease And Finance Lease Liability Current
OperatingLeaseAndFinanceLeaseLiabilityCurrent
450787
CY2019 snwv Stock Issued During Period Value Cashless Warrant Exercises With Waived Proceeds
StockIssuedDuringPeriodValueCashlessWarrantExercisesWithWaivedProceeds
36000
CY2019 snwv Reclassification Of Warrant Liability To Equity Due To Adoption Of Accounting Standard
ReclassificationOfWarrantLiabilityToEquityDueToAdoptionOfAccountingStandard
1542000
CY2019 snwv Stock Issued During Period Value Private Investment In Public Equity Pipe
StockIssuedDuringPeriodValuePrivateInvestmentInPublicEquityPIPE
2800100
CY2020 snwv Stock Issued During Period Value Private Investment In Public Equity Pipe
StockIssuedDuringPeriodValuePrivateInvestmentInPublicEquityPIPE
12682516
CY2019 snwv Stock Issued During Period Warrants Exercised Value
StockIssuedDuringPeriodWarrantsExercisedValue
3621959
CY2020 snwv Stock Issued During Period Warrants Exercised Value
StockIssuedDuringPeriodWarrantsExercisedValue
10000
CY2020 snwv Stock Issued During Period Value Inducement Shares
StockIssuedDuringPeriodValueInducementShares
44740
CY2020 snwv Stock Issued During Period Value Conversion Of Preferred Stock To Common Stock
StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStock
2450000
CY2020 snwv Adjustments To Additional Paid In Capital Warrant Liability
AdjustmentsToAdditionalPaidInCapitalWarrantLiability
249049
CY2019 snwv Stock Issued During Period Value Cashless Warrant Exercises
StockIssuedDuringPeriodValueCashlessWarrantExercises
0
CY2020 snwv Percentage Of Rent Adjustment
PercentageOfRentAdjustment
0.03
CY2020Q3 snwv Percentage Of Rent Adjustment
PercentageOfRentAdjustment
0.02
CY2020Q4 snwv Monthly Rent Payable
MonthlyRentPayable
14651
CY2020Q3 snwv Monthly Rent Payable
MonthlyRentPayable
7051
CY2020Q3 snwv Monthly Payments For Office Equipment Leased
MonthlyPaymentsForOfficeEquipmentLeased
669
CY2020Q3 snwv Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
1859965
CY2020Q3 snwv Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
436815
CY2020Q3 snwv Asset Acquisition Goodwill
AssetAcquisitionGoodwill
7259795
CY2020Q3 snwv Asset Acquistion Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
AssetAcquistionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
24000000
CY2020Q3 snwv Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
14443425
CY2020Q3 snwv Asset Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
AssetAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
0
CY2020 snwv Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
100000
CY2019 snwv Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
1158656
CY2019 snwv Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
1365000
CY2020 snwv Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
189182645
CY2020 snwv Initial Warranty Period Of Device Product
InitialWarrantyPeriodOfDeviceProduct
P1Y
CY2020 snwv Extended Warranty Period Of Device Product
ExtendedWarrantyPeriodOfDeviceProduct
P1Y
CY2019 snwv Number Of Distributors And Partners
NumberOfDistributorsAndPartners
3
CY2020 snwv Number Of Suppliers
NumberOfSuppliers
3
CY2019 snwv Number Of Suppliers
NumberOfSuppliers
1
CY2020Q4 snwv Notes And Loans Payable Gross
NotesAndLoansPayableGross
15139972
CY2019Q4 snwv Notes And Loans Payable Gross
NotesAndLoansPayableGross
587233
CY2019Q4 snwv Warrant Liability Warrants Outstanding
WarrantLiabilityWarrantsOutstanding
0
CY2020Q4 snwv Warrant Liability Warrants Outstanding
WarrantLiabilityWarrantsOutstanding
48091160
CY2020Q4 snwv Warrant Liability Fair Value Per Share
WarrantLiabilityFairValuePerShare
0.18
CY2019Q4 snwv Warrant Liability Fair Value Per Share
WarrantLiabilityFairValuePerShare
0
CY2019Q4 snwv Warrant Liability Fair Value
WarrantLiabilityFairValue
0
CY2020Q4 snwv Warrant Liability Fair Value
WarrantLiabilityFairValue
8855380
CY2020Q3 snwv Warrants Issued To Investors And Underwriter
WarrantsIssuedToInvestorsAndUnderwriter
132816250
CY2020Q3 snwv Exercise Amount Of Warrants Prior To Adjustment
ExerciseAmountOfWarrantsPriorToAdjustment
350000
CY2020 snwv Loss Gain On Warrant Liability
LossGainOnWarrantLiability
-3192620
CY2019Q4 snwv Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
751921
CY2020Q4 snwv Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
842097
CY2019Q4 snwv Operating Lease And Finance Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAccumulatedAmortization
185841
CY2020Q4 snwv Operating Lease And Finance Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAccumulatedAmortization
573290
CY2019Q4 snwv Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
152368
CY2020Q4 snwv Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
339032
CY2019Q4 snwv Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
927590
CY2020Q4 snwv Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
1368121
CY2020Q4 snwv Operating Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseRightOfUseAssetAfterAccumulatedAmortization
385572
CY2019Q4 snwv Operating Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseRightOfUseAssetAfterAccumulatedAmortization
323661
CY2019Q4 snwv Deferred Tax Assets Tax Deferred Expense Equity Cost
DeferredTaxAssetsTaxDeferredExpenseEquityCost
49471
CY2020Q4 snwv Deferred Tax Assets Tax Deferred Expense Equity Cost
DeferredTaxAssetsTaxDeferredExpenseEquityCost
49471
CY2019Q4 snwv Accrued Board Of Director Fees Current
AccruedBoardOfDirectorFeesCurrent
400000
CY2020Q4 snwv Accrued Board Of Director Fees Current
AccruedBoardOfDirectorFeesCurrent
320000
CY2020Q4 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
263750
CY2019Q4 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
0
CY2020Q4 snwv Accrued Inventory Current
AccruedInventoryCurrent
91493
CY2019Q4 snwv Accrued Inventory Current
AccruedInventoryCurrent
167050
CY2019Q4 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
0
CY2020Q4 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
335517
CY2019Q4 snwv Accrued Outside Services
AccruedOutsideServices
108033
CY2020Q4 snwv Accrued Outside Services
AccruedOutsideServices
346895
CY2019 snwv Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount
-47810
CY2020 snwv Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount
670450
CY2020Q3 snwv Number Of Human Tissue Biologic Products Combined
NumberOfHumanTissueBiologicProductsCombined
2
CY2020Q3 snwv Number Of Highly Complementary And Market Cleared Energy Transfer Technologies Combined
NumberOfHighlyComplementaryAndMarketClearedEnergyTransferTechnologiesCombined
2
CY2019 snwv Conversion Of Line Of Credit Related Party To Future Payments
ConversionOfLineOfCreditRelatedPartyToFuturePayments
90000
CY2019 snwv Conversion Of Line Of Credit Related Party To Payments
ConversionOfLineOfCreditRelatedPartyToPayments
121000

Files In Submission

Name View Source Status
0001140361-21-035116-index-headers.html Edgar Link pending
0001140361-21-035116-index.html Edgar Link pending
0001140361-21-035116.txt Edgar Link pending
0001140361-21-035116-xbrl.zip Edgar Link pending
brhc10029287_10k.htm Edgar Link pending
brhc10029287_ex21-1.htm Edgar Link pending
brhc10029287_ex23-1.htm Edgar Link pending
brhc10029287_ex31-1.htm Edgar Link pending
brhc10029287_ex31-2.htm Edgar Link pending
brhc10029287_ex32-1.htm Edgar Link pending
brhc10029287_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snwv-20201231.xml Edgar Link completed
snwv-20201231.xsd Edgar Link pending
snwv-20201231_cal.xml Edgar Link unprocessable
snwv-20201231_def.xml Edgar Link unprocessable
snwv-20201231_lab.xml Edgar Link unprocessable
snwv-20201231_pre.xml Edgar Link unprocessable